STOCK TITAN

Neolara Financials

NELR
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE June

This page shows Neolara (NELR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NELR FY2025

Improving gross economics are being overwhelmed by a financing-dependent overhead structure that still drains cash.

Across the last three filings, gross margin expansion lifted the gross profile to 76.4% from 38.5%, indicating that each sale carried more room to cover fixed costs. Yet cash conversion deteriorated as operating cash outflow widened to -$41K from -$10K, showing that better sale-level economics were overwhelmed by the cost base rather than translating into self-funding operations.

External funding of $12K covered only part of the operating cash drain of -$41K in the latest year, so financing is no longer keeping pace with the burn. That mismatch helps explain why cash finished at just $1K, leaving very little internal cushion if expenses rise or funding timing slips.

The latest filing shows selling and administrative expense of $43K against gross profit of only $22K, which means the problem sits below the gross line: overhead is absorbing more resources than the core transaction produces. Negative equity of -$23K confirms that repeated losses have already consumed the capital base rather than building retained earning power.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 17 / 100
Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Neolara's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
100

Neolara's revenue surged 36.9% year-over-year to $29K, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage
0

Neolara has elevated debt relative to equity (D/E of -3.89), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Piotroski F-Score Weak
3/9

Neolara passes 3 of 9 financial strength tests. No profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
1.71x

For every $1 of reported earnings, Neolara generates $1.71 in operating cash flow (-$41K OCF vs -$24K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$29K
YoY+36.9%

Neolara generated $29K in revenue in fiscal year 2025. This represents an increase of 36.9% from the prior year.

EBITDA
N/A
Net Income
-$24K
YoY-64.8%

Neolara reported -$24K in net income in fiscal year 2025. This represents a decrease of 64.8% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$1K
YoY-96.5%

Neolara held $1K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
3M
YoY+0.0%

Neolara had 3M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
76.4%
YoY+11.8pp

Neolara's gross margin was 76.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 11.8 percentage points from the prior year.

Operating Margin
N/A
Net Margin
-81.3%
YoY-13.8pp

Neolara's net profit margin was -81.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 13.8 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

NELR Income Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Revenue $0 $0 $0 N/A $10K+25.0% $8K $0 N/A
Cost of Revenue $0 $0 $0 N/A $2K+32.8% $2K $0 N/A
Gross Profit $0 $0 $0 N/A $8K+23.0% $6K $0 N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $3K-69.9% $9K+22.1% $7K N/A $25K+139.0% $11K+170.4% $4K N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $0 $0 $0 N/A $0 $0 $0 N/A
Net Income -$3K+69.9% -$9K+88.1% -$74K N/A -$18K-263.9% -$5K-9.2% -$5K N/A
EPS (Diluted) $0.00 $0.00+100.0% $-0.02 N/A $-0.01 $0.00 $0.00 N/A

NELR Balance Sheet

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Total Assets $15K0.0% $15K $0-100.0% $67K+31.7% $51K-35.1% $79K+6.4% $74K-5.8% $79K
Current Assets $15K0.0% $15K $0-100.0% $21K+445.8% $4K-87.7% $31K+21.3% $25K-13.3% $29K
Cash & Equivalents $0 $0 $0-100.0% $1K-72.8% $4K-65.1% $11K+99.7% $5K-81.4% $29K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $117-68.6% $373-81.8% $2K-97.7% $91K+15.4% $79K-10.8% $88K+12.4% $79K0.0% $79K
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $15K+1.8% $15K+813.2% -$2K+91.2% -$23K+15.1% -$27K-197.1% -$9K-118.1% -$4K-1329.3% $345
Retained Earnings -$144K-1.9% -$141K-6.6% -$132K-125.1% -$59K+6.6% -$63K-40.7% -$45K-12.6% -$40K-13.0% -$35K

NELR Cash Flow Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Operating Cash Flow -$3K+88.6% -$25K-377.4% -$5K+63.9% -$15K-102.4% -$7K-234.3% $5K+122.7% -$24K-443.1% -$4K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $3K-88.6% $25K+492.3% $4K-64.2% $12K N/A N/A $0-100.0% $670
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

NELR Financial Ratios

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Gross Margin 78.5% N/A N/A N/A 78.5%-1.3pp 79.7% N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin -27.1% N/A N/A N/A -187.0%-122.7pp -64.2% N/A N/A
Return on Equity -17.8%+42.2pp -60.0% N/A N/A N/A N/A N/A N/A
Return on Assets -17.6%+40.9pp -58.5% N/A N/A -35.6%-29.2pp -6.3%-0.2pp -6.2% N/A
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 0.01-0.0 0.03+1.0 -1.00+2.9 -3.89-1.0 -2.86+6.7 -9.54+9.0 -18.51-246.0 227.54
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$23K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

Neolara (NELR) reported $29K in total revenue for fiscal year 2025. This represents a 36.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Neolara (NELR) revenue grew by 36.9% year-over-year, from $21K to $29K in fiscal year 2025.

No, Neolara (NELR) reported a net income of -$24K in fiscal year 2025, with a net profit margin of -81.3%.

Neolara (NELR) had a gross margin of 76.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Neolara (NELR) had a net profit margin of -81.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Neolara (NELR) generated -$41K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Neolara (NELR) had $67K in total assets as of fiscal year 2025, including both current and long-term assets.

Neolara (NELR) had 3M shares outstanding as of fiscal year 2025.

Neolara (NELR) had a debt-to-equity ratio of -3.89 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Neolara (NELR) had a return on assets of -35.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Neolara (NELR) had $1K in cash against an annual operating cash burn of $41K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Neolara (NELR) has negative shareholder equity of -$23K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Neolara (NELR) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Neolara (NELR) has an earnings quality ratio of 1.71x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Neolara (NELR) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top